Track topics on Twitter Track topics that are important to you
At Kite, Shaw will focus on turning around the company's flagship CAR-T treatment Yescarta, as well as focus on the development of other cancer-targeting cell therapies.
Original Article: Eli Lilly’s Christi Shaw to Take Over Helm of Kite PharmaNEXT ARTICLE
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...